Evidence map›Paper›PMID 28271331›Full record

ArticleTechniques in coloproctology2017

Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution.

A Wilhelm, A Fiebig, M Krawczak

3 registry-linked trialsOpen access · hybridAbstract readEvaluation Study
In one paragraph

Article in Techniques in coloproctology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 61 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 11 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04161469 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Laser Closure of Anal Fistula (FiLaC); Do we Need to Close Internal Orifice?

TypeinterventionalSponsorSurp Pırgiç Armenian HospitalRan2019 to 2020Enrolled80ConditionsAnal Fistula, Fistula in Ano, Sphincter Ani IncontinenceArmsLaser closure of the anal fistula tract (FiLaC), Internal orifice closure
NCT04508374 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa: Protocol for a Within-person Randomised Trial

TypeinterventionalSponsorZealand University HospitalRan2020 to 2025Enrolled20ConditionsHidradenitis SuppurativaArms1470 nm intra-lesional diode laser treatment of right HS tunnel, 1470 nm intra-lesional diode laser treatment of left HS tunnel
NCT07452666 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

FISTULA-RFA Trial (Fistula Inactivation by Segmental Thermal Uniform Lesion Ablation-Radiofrequency Ablation): A Prospective, Multicenter, Single-Arm Pilot Study in Patients With Perianal Fistula

TypeinterventionalSponsorKorea University Ansan HospitalRan2026 to 2027Enrolled80ConditionsRectal FistulasArmsRadiofrequency Ablation (RFA) for Perianal Fistula
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 11 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Pooled it
  12. Article
  13. Article
  14. Article
  15. Core-Out Fistulectomy Combined With Laser Ablation of the Trans-Sphincteric Fistula Tract: A Pilot Study of Efficacy and Safety.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  16. Ligation of the intersphincteric fistula tractWorld journal of gastrointestinal surgery · 2026
    Article
  17. Article
  18. Article
  19. Evidence outside the box: Minimally invasive treatment for anal fistula.World journal of gastrointestinal surgery · 2025
    Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

A WilhelmCenter of Colorectal and Pelvic Floor Diseases, Aachener Str. 1006-12, 50858, Cologne, Germany. arne.wilhelm@ebzkoeln.de.
A FiebigCompetence Network of Chronic Venous Diseases, Kiel, Germany.
M KrawczakInstitute of Medical Informatics and Statistics, Christian-Albrechts-University, Kiel, Germany.
Clinical Research Center Kiel · DEKiel University · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are limited data available concerning endofistular therapies for fistula-in-ano, with our group reporting the first preliminary outcomes of the use of the radial fibre Fistula laser Closing (FiLaC ™) device.

methodsThe aim of this study was to assess a cohort of anal fistulae managed with laser ablation plus definitive flap closure of the internal fistula opening over a long-term follow-up. Factors governing primary healing success and secondary healing success (i.e. success after one or two operations) were determined.

resultsThe study analysed 117 patients over a median follow-up period of 25.4 months (range 6-60 months) with 13 patients (11.1%) having Crohn's-related fistulae. No incontinence to solid and liquid stool was reported. Minor incontinence to mucus and gas was observed in two cases (1.7%), and a late abscess treated in one case (0.8%). The primary healing rate was 75/117 (64.1%) overall, and 63.5% for cryptoglandular fistulae versus 69.2% for Crohn's fistulae, respectively. Of the 42 patients who failed FiLaC™ 31 underwent a second operation ("Re-FiLaC™", fistulectomy with sphincter reconstruction or fistulotomy). The secondary healing rate, defined as healing of the fistula at the end of the study period, was 103/117 (88.0%) overall and 85.5% for cryptoglandular fistulae versus 92.3% for Crohn's fistulae. A significantly higher primary success rate was observed for intersphincteric-type fistulae with primary and secondary outcome unaffected by age, gender, presence of Crohn's disease, number of prior surgeries and the type of flap designed to close the internal fistula opening.

conclusionsThere is a moderate primary success rate using first-up FiLaC™ treatment. If FiLaC™ fails, secondary success with repeat FiLaC™ or other approaches was high. The minimally invasive FiLaC™ approach may therefore represent a sensible first-line treatment option for anal fistula repair.

Indexed as

Surgical FlapsAdultAgedAnal CanalCrohn DiseaseEndoscopy, GastrointestinalFemaleFollow-Up StudiesHumansLaser TherapyMaleMiddle AgedRectal FistulaTreatment OutcomeWound HealingAnal fistulaFaecal incontinenceFiLaCLaserRepairSphincter-preserving

Identifiers

PMID28271331
PMCPMC5423928
OpenAlexW2593057414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.